… In addition to therapeutic properties of these anti-COVID-19 compounds, some adverse …
therapy and treatment of COVID-19, but also nanomedicine, immunotherapy, and cell therapy …

… as the causing agent of COVID-19, has affected all over the … confirmed cases of COVID-19
infection and 464,483 deaths … therapy or vaccine available for the treatment of COVID-19. …

… As a future prospect, we propose improving the vitamin D plasma levels of the world
population, especially of those individuals with additional risk factors that predispose them to the …

… , raising concerns about the safety of these COVID-19 vaccines. Here, we systemically
assess the safety and efficacy of COVID-19 vaccines, including the possible complications and …

… The coronavirus infection termed COVID-19 is caused by the virus leading to a severe
acute … On 11 March 2020, the World Health Organization (WHO) declared COVID-19 as a …

… potential of quercetin as a drug in the treatment of COVID-19 from a molecular perspective.
… that causes coronavirus disease 2019 (COVID-19). A previously known coronavirus was …

… latest information about COVID-19 diagnostics, potential therapeutic options, and vaccine
development to summarize the current understanding of COVID-19. COVID-19 Therapeutics …

… no decisive therapy for COVID-19 or related complications. The development of COVID-19
vaccines … based on the intercross immunity induced by COVID-19. Thus far, several types of …

… severe COVID-19 and is usually administered by serum from several other patients with
COVID 19. The current technology related to the transfusion of COVID-19 is discussed below: …

… to COVID-19 … COVID-19 as compared to nonsmokers. It should be mentioned that our
primary observations during the first COVID-19 outbreak (February-April 2020) on 206 COVID-19 …